Medtech industry in 2009: Ernst & Young presents the good, the bad and the ugly
This article was originally published in Clinica
Executive Summary
The medtech industry’s balance sheets were very healthy in 2009. That is one of the key positive findings from Ernst & Young's annual report on the medtech industry, which is officially launched today at the AdvaMed conference in Washington, DC.